Okamoto, H., Shibazaki, N., Yoshimura, T., Uzawa, T., & Sugimoto, T. (2020). Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis. Osteoporos Sarcopenia.
Citação norma ChicagoOkamoto, Hiroaki, Nayumi Shibazaki, Takeshi Yoshimura, Toyonobu Uzawa, and Toshitsugu Sugimoto. "Association between Elcatonin Use and Cancer Risk in Japan: A Follow-up Study After a Randomized, Double-blind, Placebo-controlled Study of Once-weekly Elcatonin in Primary Postmenopausal Osteoporosis." Osteoporos Sarcopenia 2020.
MLA CitationOkamoto, Hiroaki, et al. "Association between Elcatonin Use and Cancer Risk in Japan: A Follow-up Study After a Randomized, Double-blind, Placebo-controlled Study of Once-weekly Elcatonin in Primary Postmenopausal Osteoporosis." Osteoporos Sarcopenia 2020.